公司资料
Salarius Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- SLRX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for SLRX.
公司概览
业务概览
Salarius Pharmaceuticals is a biotechnology company focused on oncology and epigenetic or related cancer biology. Its story is built around seeking targeted cancer therapies for difficult tumors.
所在地与行业分类
Salarius is headquartered in the United States and listed on NASDAQ. It sits in small-cap oncology biotechnology.
商业模式特征
The company depends on clinical data, partnership options, and capital discipline. Investors usually track early readouts and whether the pipeline can maintain enough momentum to matter.
生物医药行业定位
Salarius occupies a catalyst-sensitive oncology niche within biotech. The stock is driven by proof-of-concept and the market's confidence in the company's cancer thesis.
未来催化剂
- Salarius is a legacy / closeout story now, so the catalysts are any remaining strategic or asset-resolution update rather than a live oncology milestone. The market is mainly focused on residual value.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。